Nanitebio

Boston, US · Founded 2020 · 2 known investors

Nanite develops polymer nanoparticles for gene therapy delivery using AI-driven design and high-throughput synthesis. The company creates virus-free, resorbable delivery vectors for DNA and genetic drugs, targeting applications in genetic medicine.

AI & Machine LearningBiotechNew Materialsin /naniteinc @nanitebio

Founders & leadership

Shashi MurthyExecutive Officer

Sean KevlahanExecutive Officer, Director, Promoter

Thomas X. NeenanExecutive Officer

Investors · 2

Bantam GroupWestwood

Civilization Ventures Management, LlcTiburon · $1M – $10M

Reported raises · per SEC filings

Form D private placements

▶$4.1MraisedMay 2022 · 11 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Shashi MurthyExecutive Officer
Sean KevlahanExecutive Officer, Director, Promoter
Thomas X. NeenanExecutive Officer

Offering amount: $6.1M
Amount sold: $4.1M
First sale: May 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.